FDA Adds Rare Vision-Loss Warning To All GLP-1 Diabetes And Weight Drugs
2h
Developing
2
The Food and Drug Administration has ordered new warnings on all GLP-1 diabetes and weight-loss drugs about a possible risk of a rare eye condition that can cause sudden, permanent vision loss, telling patients and prescribers to watch for abrupt vision changes but not to stop the medications on their own. CBS News
